Search for Clinical Trial Results

Sponsored By

Hyperphosphatemia - 25 Studies Found

Status Study
Recruiting Study Name: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
Condition: Hyperphosphatemia
Date: 2016-07-14
Interventions:
  • Drug: Nicotinic Acids Nicotini
Completed Study Name: A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Condition: Hemodialysis Patients With Hyperphosphatemia
Date: 2013-04-12
Interventions: Drug: PA21
Recruiting Study Name: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
Condition: Hyperphosphatemia
Date: 2016-02-09
Interventions: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro
Recruiting Study Name: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
Condition: Hyperphosphatemia
Date: 2016-02-17
Interventions:
  • Drug: PA21 (Velphoro®)

Completed Study Name: Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Condition: Hyperphosphataemia
Date: 2014-05-28
Interventions:
  • Drug: PT20 Modified ferric oxi
Not yet recruiting Study Name: Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
Condition: Hyperphosphatemia
Date: 2016-12-20
Interventions:
  • Drug: Placebo

Recruiting Study Name: A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Condition: Hyperphosphatemia
Date: 2016-11-11
Interventions:
  • Drug: EOS789
  • Drug: Placebo
Completed Study Name: An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Condition: Hyperphosphatemia
Date: 2016-02-03
Interventions:
  • Drug: Tenapanor Other Name: RD
Completed Study Name: Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
Condition: Hyperphosphatemia
Date: 2012-01-18
Interventions: Drug: Lanthanum Carbonate (BAY77-1931)
Completed Study Name: Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
Condition: Hyperphosphatemia
Date: 2012-01-18
Interventions:
  • Drug: Lanthanum carbonate (BAY77-1931)
  • Dru
Next >>>